Literature DB >> 16922259

Radiation therapy in the treatment of cholangiocarcinoma.

Brian G Czito1, Mitchell S Anscher, Christopher G Willett.   

Abstract

The prognosis of patients with biliary cancers is poor. Although surgery is potentially curative in selected patients, local recurrence is a common pattern of failure. Adjuvant or neoadjuvant radiation therapy improves local control and possibly survival. In locally advanced patients, radiation therapy provides palliation and may prolong survival. Concurrently administered chemotherapy may further enhance these results. Newer radiation therapy techniques, including intraluminal transcatheter brachytherapy, intraoperative radiation therapy, intensity-modulated radiation therapy, and three- and four-dimensional treatment planning, permit radiation dose escalation without significant increases in normal tissue toxicity, thereby increasing the effective radiation dose. Preliminary results of studies employing hepatic transplantation with radiation therapy are encouraging. Although these new approaches hold promise, the prognosis in patients with biliary cancers remains poor, and the integration of novel therapeutic strategies is indicated.

Entities:  

Mesh:

Year:  2006        PMID: 16922259

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  13 in total

1.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Authors:  Al B Benson; Thomas A Abrams; Edgar Ben-Josef; P Mark Bloomston; Jean F Botha; Bryan M Clary; Anne Covey; Steven A Curley; Michael I D'Angelica; Rene Davila; William D Ensminger; John F Gibbs; Daniel Laheru; Mokenge P Malafa; Jorge Marrero; Steven G Meranze; Sean J Mulvihill; James O Park; James A Posey; Jasgit Sachdev; Riad Salem; Elin R Sigurdson; Constantinos Sofocleous; Jean-Nicolas Vauthey; Alan P Venook; Laura Williams Goff; Yun Yen; Andrew X Zhu
Journal:  J Natl Compr Canc Netw       Date:  2009-04       Impact factor: 11.908

Review 2.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 3.  Cholangiocarcinoma--controversies and challenges.

Authors:  Tushar Patel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

Review 4.  External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence.

Authors:  Puja Sahai; Senthil Kumar
Journal:  Br J Radiol       Date:  2017-05-23       Impact factor: 3.039

5.  Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis.

Authors:  Hari Nathan; Timothy M Pawlik; Christopher L Wolfgang; Michael A Choti; John L Cameron; Richard D Schulick
Journal:  J Gastrointest Surg       Date:  2007-09-05       Impact factor: 3.452

6.  The role of postoperative radiation therapy (PORT) in the treatment of extrahepatic bile duct cancer: a surveillance, epidemiology, and end results (SEER) population-based investigation.

Authors:  James B Yu; Roy H Decker; Jonathan P S Knisely
Journal:  J Gastrointest Cancer       Date:  2009-01-21

7.  Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey.

Authors:  Fumiaki Isohashi; Kazuhiko Ogawa; Hirobumi Oikawa; Hiroshi Onishi; Nobue Uchida; Toshiya Maebayashi; Naoto Kanesaka; Tetsuro Tamamoto; Hirofumi Asakura; Takashi Kosugi; Takashi Uno; Yoshinori Ito; Katsuyuki Karasawa; Makoto Takayama; Yoshihiko Manabe; Hideya Yamazaki; Mitsuhiro Takemoto; Yasuo Yoshioka; Kenji Nemoto; Yasumasa Nishimura
Journal:  Radiat Oncol       Date:  2013-04-01       Impact factor: 3.481

8.  Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.

Authors:  Marta Bonet Beltrán; Arnaud D Roth; Gilles Mentha; Abdelkarim S Allal
Journal:  BMC Cancer       Date:  2011-06-24       Impact factor: 4.430

9.  Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.

Authors:  Joanna Gotfrit; Rachel Goodwin; Timothy Asmis; Angela J Hyde; Thierry Alcindor; Francine Aubin; Scott Berry; Dominick Bossé; Colin Brown; Ronald Burkes; Margot Burnell; Bruce Colwell; Jessica Corbett; Jeff Craswell; Nathalie Daaboul; Mark Doherty; D A Barry Fleming; Luisa Galvis; Rakesh Goel; Mohammed Harb; Alwin Jeyakumar; Derek Jonker; Erin Kennedy; Michael Lock; Aamer Mahmud; Patrick H McCrea; Vimoj Nair; Rami Nassabein; Carolyn Nessim; Ravi Ramjeesingh; Muhammad Raza; Wissam Saliba; Satareh Samimi; Simron Singh; Stephanie Snow; Mustapha Tehfé; Michael Thirlwell; Mario Valdes; Stephen Welch; Michael Vickers
Journal:  Curr Oncol       Date:  2021-05-26       Impact factor: 3.677

10.  Two cases of humoral hypercalcemia of malignancy in metastatic cholangiocarcinoma.

Authors:  Seungtaek Lim; Jungwoo Han; Kyeong Hye Park; Won Jai Jung; Yong Kang Lee; Ara Choi; Young Jae Kim; Jong-Chan Lee; Hye Jin Choi
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.